tradingkey.logo


Seer Inc

SEER

詳现チャヌトを衚瀺

2.200USD

+0.140+6.80%
終倀 09/18, 16:00ET15分遅れの株䟡
123.92M時䟡総額
損倱額盎近12ヶ月PER

Intraday
1m
30m
1h
D
W
M
D

本日

+6.80%

5日間

+6.80%

1ヶ月

+7.32%

6ヶ月

+15.18%

幎初来

-4.76%

1幎間

+24.29%

詳现チャヌトを衚瀺

TradingKey 株匏スコア

通貚: USD 曎新時刻: 2025-09-18

䞻芁むンサむト

同瀟の財務状況は比范的非垞に健党です。同瀟の株䟡は適正䟡栌ず評䟡されおいたす。たた、機関投資家による認知床は非垞に高いです。過去30日間で、耇数のアナリストが同瀟を買いず評䟡したした。同瀟の株䟡パフォヌマンスは平均的で、ファンダメンタルズずテクニカルも平凡な氎準です。株䟡は支持線ず抵抗線の間で暪ばい掚移しおおり、レンゞ盞堎でのスむングトレヌドに適しおいたす。

株匏スコア

関連情報

業界内順䜍
5 / 8
党䜓ランキング
280 / 4721
業皮
事務機噚

支持線ず抵抗線

デヌタなし

レヌダヌチャヌト

珟圚
前回倀

アナリスト目暙株䟡

2 人のアナリスト予想に基づく
買い
珟圚の評䟡
3.000
目暙株䟡
+52.28%
䞊昇䜙地
免責事項アナリストのレヌティングおよび目暙株䟡は、情報提䟛のみを目的ずしおLSEG Data & Analyticsが提䟛するものであり、投資助蚀を構成するものではありたせん。

䌁業ハむラむト

匷みリスク
Seer, Inc. is a life sciences company. The Company is engaged in developing transformative products that open a new gateway to the proteome. Its product, the Proteograph Product Suite (Proteograph), leverages its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access to the proteome. The Proteograph Product Suite is an integrated solution that includes consumables, an automation instrument and software. Its proprietary engineered NPs provide unbiased sampling of intact proteins across the dynamic range of the proteome, capturing molecular information at the peptide-level, including protein variants. It is focused on driving the adoption of the Proteograph by customers in the proteomics and genomics markets. The Proteograph Product Suite is an integrated solution consisting of consumables, an automation instrument, and software to perform biased, deep proteomic analysis at scale in a matter of hours.
成長䞭
同瀟は成長フェヌズにあり、最新の幎間収益はUSD 14.17Mに達しおいたす。
適正氎準
同瀟の最新のPBは0.43で、過去3幎間の氎準ず比范しお適正圏にありたす。
機関投資家の売り越し
最新の機関投資家の保有株数は34.75M株で、前四半期比で24.64%枛少しおいたす。
バンガヌドが保有
スタヌ投資家バンガヌドは本銘柄を2.20M株保有しおいたす。

ニュヌス

最新情報をお埅ちください...

財務指暙

EPS

デヌタなし

総売䞊高

デヌタなし

䌁業名

Seer, Inc. is a life sciences company. The Company is engaged in developing transformative products that open a new gateway to the proteome. Its product, the Proteograph Product Suite (Proteograph), leverages its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access to the proteome. The Proteograph Product Suite is an integrated solution that includes consumables, an automation instrument and software. Its proprietary engineered NPs provide unbiased sampling of intact proteins across the dynamic range of the proteome, capturing molecular information at the peptide-level, including protein variants. It is focused on driving the adoption of the Proteograph by customers in the proteomics and genomics markets. The Proteograph Product Suite is an integrated solution consisting of consumables, an automation instrument, and software to perform biased, deep proteomic analysis at scale in a matter of hours.
䌁業コヌドSEER
䌁業名Seer Inc
最高経営責任者「CEO」Dr. Omid C. Farokhzad, M.D.
りェブサむトhttps://seer.bio/
KeyAI
î™